The Nutshell

» cancer and policy

Daily News Roundup

Most Recent

The Oracle cofounder’s gift will fund a new institute at the University of Southern California.

0 Comments

image: Tasmanian Devil Antibodies Fight Cancer

Tasmanian Devil Antibodies Fight Cancer

By | May 9, 2016

The proteins could be the key to stopping the transmissible facial tumor disease that is threatening the species.

0 Comments

image: Speaking of Cancer Research

Speaking of Cancer Research

By , , and | April 20, 2016

A selection of notable quotes from the annual American Association for Cancer Research meeting

0 Comments

image: Two NIH Labs Cease Reagent Production

Two NIH Labs Cease Reagent Production

By | April 20, 2016

Contamination concerns at cell therapy and radioactive tracer facilities spur production shutdowns.

0 Comments

image: AACR Q&A: Angelika Amon

AACR Q&A: Angelika Amon

By | April 19, 2016

The aneuploidy expert shares what she has learned at the American Association for Cancer Research annual meeting.

0 Comments

image: Running from Cancer?

Running from Cancer?

By | April 18, 2016

At the American Association for Cancer Research annual meeting, researchers review the evidence that exercise has antitumor benefits.

0 Comments

image: AACR Q&A: Elaine Mardis

AACR Q&A: Elaine Mardis

By | April 18, 2016

The genomics pioneer shares the sessions she most looks forward to at this year’s American Association for Cancer Research annual meeting.

0 Comments

image: Cancer Tissue Repository Launched

Cancer Tissue Repository Launched

By | April 11, 2016

The Dana-Farber Cancer Institute will store tissue samples from patients with leukemia and lymphoma from which scientists can make patient-derived mouse models.

0 Comments

image: Pfizer-Allergan Merger Scrapped

Pfizer-Allergan Merger Scrapped

By | April 7, 2016

A move by the US federal government to close tax loopholes that encourage “tax inversions” likely spooked the companies out of the multibillion dollar deal.

0 Comments

image: Dying Light Marks the Spot

Dying Light Marks the Spot

By | March 29, 2016

Drug-delivering nanoparticles designed to glow when their target cells die can report on the effectiveness of cancer therapies within just a few hours of treatment, a mouse study shows.

0 Comments

Popular Now

  1. Broad Wins CRISPR Patent Interference Case
    Daily News Broad Wins CRISPR Patent Interference Case

    The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.

  2. Henrietta Lacks’s Family Seeks Compensation
  3. Can Plants Learn to Associate Stimuli with Reward?
  4. Humans Never Stopped Evolving
    Features Humans Never Stopped Evolving

    The emergence of blood abnormalities, an adult ability to digest milk, and changes in our physical appearance point to the continued evolution of the human race.

Business Birmingham